colforsin has been researched along with Hearing Loss in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Choung, YH; Jang, JH; Kim, H; Kim, YJ; Lee, JS | 1 |
| Bai, X; Guo, X; Li, J; Li, L; Wang, H | 1 |
| Bichara, M; Escoubet, B; Ferrary, E; Friedlander, G; Grayeli, AB; Julien, N; Silve, C; Sterkers, O | 1 |
3 other study(ies) available for colforsin and Hearing Loss
| Article | Year |
|---|---|
Gap Junction-Mediated Intercellular Communication of cAMP Prevents CDDP-Induced Ototoxicity via cAMP/PKA/CREB Pathway.
Topics: A549 Cells; Animals; Cell Communication; Cell Death; Cisplatin; Colforsin; Connexin 26; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Gap Junctions; Hair Cells, Auditory; Hearing Loss; HeLa Cells; Humans; Mice; Ototoxicity; Protective Agents; Rats, Sprague-Dawley; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Spiral Ganglion; Tretinoin | 2021 |
Forskolin protects against cisplatin-induced ototoxicity by inhibiting apoptosis and ROS production.
Topics: Animals; Apoptosis; Cell Line; Cell Survival; Cisplatin; Colforsin; Cyclic AMP-Dependent Protein Kinases; Ear Diseases; Hair Cells, Auditory; Hearing Loss; MAP Kinase Signaling System; Mice, Inbred C57BL; Mitochondria; Protective Agents; Reactive Oxygen Species | 2018 |
Increased activity of the diastrophic dysplasia sulfate transporter in otosclerosis and its inhibition by sodium fluoride.
Topics: Adult; Alkaline Phosphatase; Analysis of Variance; Anion Transport Proteins; Biological Transport; Carrier Proteins; Case-Control Studies; Cells, Cultured; Colforsin; Ear Canal; Female; Hearing Loss; Humans; Male; Membrane Transport Proteins; Middle Aged; Osteochondrodysplasias; Otosclerosis; Phenotype; Sodium Fluoride; Stapes; Sulfate Transporters; Verapamil | 2003 |